<!doctype html>
<html lang="id">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width,initial-scale=1" />
  <title>Nuclear Medicine - Medical Physicist</title>
  <style>
    body{font-family:Arial, sans-serif;margin:0;background:#f6f8fa;color:#0f172a}
    header{background:#0b6d8a;color:#fff;padding:20px}
    nav a{color:#fff;margin-right:15px;text-decoration:none}
    .container{max-width:1000px;margin:20px auto;padding:0 15px}
    .article{background:#fff;padding:15px;margin-bottom:15px;border-radius:8px;box-shadow:0 2px 5px rgba(0,0,0,0.1)}
    .article h2{margin:0}
    .article p{color:#555}
  </style>
</head>
<body>
<header>
  <h1>Nuclear Medicine</h1>
  <nav>
    <a href="home.html">Home</a>
    <a href="nuclear medicine/history-of-nuclear-medicine.html">History of Nuclear Medicine</a>
    <a href="nuclear medicine/instrumentation-of-nuclear-medicine.html">Instrumentation of Nuclear Medicine</a>
    <a href="nuclear medicine/modalities-of-nuclear-medicine.html">Modalities of Nuclear Medicine</a>

  </nav>
</header>
<div class="container">

    <p><b>Nuclear Medicine</b> is a specialty that uses small amounts of radioactive materials (radiopharmaceuticals), administered to the patient, to diagnose and treat a variety of diseases. Its defining characteristic is the focus on physiology and function rather than anatomy.</p>
        <img src="fig/Nuclear Medicine.jpg" width="400" height="250"> 
    <hr>

    <h2>1. The Core Principle: The Radiopharmaceutical</h2>

    <p>The effectiveness of Nuclear Medicine relies entirely on the successful delivery and uptake of the radiopharmaceutical.</p>

    <ul>
        <li class="section-item"><b>Radiotracer:</b> A compound created by chemically bonding a radioactive isotope (the radionuclide) to a biologically active molecule (the pharmaceutical).</li>
        <li class="section-item"> The pharmaceutical component is designed to localize in a specific organ, tumor, or receptor site based on the body's metabolic or physiological function. The radionuclide component then emits detectable radiation.</li>
        <li class="section-item"><b>Mechanism:</b> Ideal Isotope: Must have a suitable physical half-life (long enough for imaging, short enough for low patient dose) and emit readily detectable, single-energy photons (e.g., Technetium-99m, Fluorine-18).</li>
    </ul>

    <hr>

    <h2>2. Key Modalities for Functional Imaging</h2>

    <p>These instruments detect the radiation emitted by the patient to create images of the tracer distribution:</p>

    <h3>A. Gamma Camera & SPECT (Single-Photon Imaging)</h3>
        <img src="fig/Gamma Camera & SPECT.png" width="400" height="250"> 
    <ul>
        <li class="section-item"><b>Detection:</b> Detects single gamma rays emitted from radionuclides like Tc-99m.</li>
        <li class="section-item"><b>Gamma Camera:</b> Provides a 2D planar map of tracer concentration.</li>
        <li class="section-item"><b>SPECT:</b> Provides 3D cross-sectional images by rotating the detector, significantly improving localization.</li>
        <li class="section-item"><b>SPECT/CT:</b> Fuses the 3D functional map (SPECT) with anatomical localization (CT).</li>
    </ul>

    <h3>B. PET (Positron Emission Tomography)</h3>
        <img src="fig/PET (Positron Emission Tomography).jpeg" width="400" height="250"> 
    <ul>
        <li class="section-item"><b>Detection:</b> Detects the two 511 keV photons resulting from positron annihilation. Relies on electronic coincidence detection.</li>
        <li class="section-item"><b>Tracer:</b> Uses short-lived, cyclotron-produced isotopes (e.g., F-18 in FDG).</li>
        <li class="section-item"><b>PET/CT:</b> The gold standard for oncology, providing a highly sensitive and quantitative metabolic map (PET) localized anatomically (CT).</li>
    </ul>

    <hr>

    <h2>3. Applications in Diagnosis and Therapy</h2>

    <p>Nuclear Medicine is unique in its ability to non-invasively assess function across various organ systems.</p>

    <h3>A. Diagnostic Applications</h3>
    <ul>
        <li class="section-item"><b>Oncology:</b> PET/CT with FDG for staging, restaging, and assessing treatment response in most cancers.</li>
        <li class="section-item"><b>Cardiology:</b> SPECT Myocardial Perfusion Imagin (MPI) to assess blood flow to the heart muscle.</li>
        <li class="section-item"><b>Neurology:</b> SPECT and PET for diagnosing dementia (Alzheimer's) and evaluating Parkinson's disease.</li>
        <li class="section-item"><b>Endocrinology:</b> Thyroid uptake scans and whole-body surveys using I-131 or I-123.</li>
    </ul>

    <h3>B. Therapeutic Applications (Radiopharmaceutical Therapy)</h3>
    <p>Often referred to as Molecular Radiotherapy or Theranostics (combining therapy and diagnosis).</p>
    <ul>
        <li class="section-item"><strong>Radioiodine Therapy(<sup>131</sup>I:</strong>) Used orally to ablate remnants of thyroid cancer or treat hyperthyroidism.</li>
        <li class="section-item"><b>PRRT (Peptide Receptor Radionuclide Therapy):</b>Uses radionuclides like Lutetium-177 (<sup>177</sup>Lu) to target specific receptors on cancer cells (e.g., neuroendocrine tumors).</li>
        <li class="section-item"><b>Palliative Therapy:</b> Using bone-seeking radiopharmaceuticals (e.g., Ra-223) to alleviate pain from bone metastases.</li>
    </ul>

    <hr>

    <h2>4. The Distinction from Radiology</h2>

    <div class="key-concept">
        <p>While often grouped together, the two fields address different clinical questions:</p>
        <ul>
            <li><b>Radiology (CT, MRI):</b> Focuses on Structure, Shape, and Size (Anatomy).</li>
            <li><b>Nuclear Medicine (PET, SPECT):</b> Focuses on Function, Metabolism, and Blood Flow (Physiology).</li>
        </ul>
        <p>Nuclear Medicine is crucial for detecting disease processes early, often before structural changes are visible on anatomical imaging.</p>
    </div>

</div>
</body>
</html>
